Health Care
Commentary
Cashing In On University Patents Means Giving Up On Our Innovation Future
Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation ...
Commentary
America Can’t Tariff Its Way to a Manufacturing Boom
President Trump very recently signed an executive order exempting a range of products from his proposed tariffs, including some pharmaceuticals. One day prior, he issued an order exempting generic pharmaceuticals from Japan from tariffs. It’s encouraging news, to be sure — particularly for American patients. But policies which shield vital ...
Commentary
The illicit trade in weight-loss drugs deserves a crackdown
The market for illicit weight-loss drugs is booming in plain sight. Law enforcement officials will have no choice but to act soon. In July, telehealth firm Hims & Hers was hit with a securities lawsuit alleging that the company sold unapproved knock-off compounded versions of Wegovy in violation of its ...
Commentary
Republicans Must Stand Their Ground On Enhanced Obamacare Subsidies
A group of Republican lawmakers is trying to preserve one of the worst mistakes of former President Biden’s tenure—the enhanced subsidies for health insurance sold through Obamacare’s exchanges. The subsidies—which were first enacted on an explicitly temporary basis during the pandemic before being renewed in 2022—are set to expire at ...
Commentary
Business Policy CMS Shouldn’t Expand Its Broken Competitive Bidding Model
Durable medical equipment (DME) such as CPAP machines and hospital beds helps keep many patients out of expensive nursing home care and in their own homes. Unfortunately, creating the right payment model has long eluded the Centers for Medicare and Medicaid Services (CMS). Disconcertingly, they now plan to expand a ...
Commentary
Trump’s Medicaid reform is moral and necessary
Among the most contentious provisions in the One Big Beautiful Bill Act, which President Donald Trump signed into law on July 4, are its Medicaid work requirements. Starting in 2027, able-bodied, working-age Medicaid beneficiaries enrolled through Obamacare’s expansion of the program must spend at least 80 hours a month on ...
Commentary
Thanks to Obamacare, Insurance Fraud Irresistible
Something strange is afoot on the Obamacare exchanges. According to a new study by the Paragon Health Institute, an astounding number of patients with premium-free exchange plans filed no claims whatsoever last year. It’s possible that none of these individuals required medical care in 2024. Read the op-ed here.
Commentary
Time To Crack Down On The Knock-Off Weight-Loss Drug Trade
Wegovy, Zepbound, and other GLP-1 agonists have given Americans an extraordinary new tool for losing weight and improving their health. But they’ve also given rise to a dangerous new public health threat—counterfeit medicines. In a rush to capitalize on the popularity of these drugs, a number of third-party telehealth firms ...
Commentary
Should the Government Control Drug Prices? No…
In a May 12 executive order, President Trump announced a “most favored nation” policy that intends to lower prescription drug prices. Among other things, the order directed the Secretary of Health and Human Services to “communicate most-favored-nation price targets to pharmaceutical manufacturers to bring prices . . . in line ...
Commentary
Trump Embraces Disastrous Most Favored Nation Drug Pricing
President Donald Trump gave American drug companies an ultimatum last month. Either they agree to adopt foreign-style price controls, or the administration “will deploy every tool in [its] arsenal” to do it for them. More specifically, the president asked drug firms to base U.S. drug prices for a given drug ...
Cashing In On University Patents Means Giving Up On Our Innovation Future
Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation ...
America Can’t Tariff Its Way to a Manufacturing Boom
President Trump very recently signed an executive order exempting a range of products from his proposed tariffs, including some pharmaceuticals. One day prior, he issued an order exempting generic pharmaceuticals from Japan from tariffs. It’s encouraging news, to be sure — particularly for American patients. But policies which shield vital ...
The illicit trade in weight-loss drugs deserves a crackdown
The market for illicit weight-loss drugs is booming in plain sight. Law enforcement officials will have no choice but to act soon. In July, telehealth firm Hims & Hers was hit with a securities lawsuit alleging that the company sold unapproved knock-off compounded versions of Wegovy in violation of its ...
Republicans Must Stand Their Ground On Enhanced Obamacare Subsidies
A group of Republican lawmakers is trying to preserve one of the worst mistakes of former President Biden’s tenure—the enhanced subsidies for health insurance sold through Obamacare’s exchanges. The subsidies—which were first enacted on an explicitly temporary basis during the pandemic before being renewed in 2022—are set to expire at ...
Business Policy CMS Shouldn’t Expand Its Broken Competitive Bidding Model
Durable medical equipment (DME) such as CPAP machines and hospital beds helps keep many patients out of expensive nursing home care and in their own homes. Unfortunately, creating the right payment model has long eluded the Centers for Medicare and Medicaid Services (CMS). Disconcertingly, they now plan to expand a ...
Trump’s Medicaid reform is moral and necessary
Among the most contentious provisions in the One Big Beautiful Bill Act, which President Donald Trump signed into law on July 4, are its Medicaid work requirements. Starting in 2027, able-bodied, working-age Medicaid beneficiaries enrolled through Obamacare’s expansion of the program must spend at least 80 hours a month on ...
Thanks to Obamacare, Insurance Fraud Irresistible
Something strange is afoot on the Obamacare exchanges. According to a new study by the Paragon Health Institute, an astounding number of patients with premium-free exchange plans filed no claims whatsoever last year. It’s possible that none of these individuals required medical care in 2024. Read the op-ed here.
Time To Crack Down On The Knock-Off Weight-Loss Drug Trade
Wegovy, Zepbound, and other GLP-1 agonists have given Americans an extraordinary new tool for losing weight and improving their health. But they’ve also given rise to a dangerous new public health threat—counterfeit medicines. In a rush to capitalize on the popularity of these drugs, a number of third-party telehealth firms ...
Should the Government Control Drug Prices? No…
In a May 12 executive order, President Trump announced a “most favored nation” policy that intends to lower prescription drug prices. Among other things, the order directed the Secretary of Health and Human Services to “communicate most-favored-nation price targets to pharmaceutical manufacturers to bring prices . . . in line ...
Trump Embraces Disastrous Most Favored Nation Drug Pricing
President Donald Trump gave American drug companies an ultimatum last month. Either they agree to adopt foreign-style price controls, or the administration “will deploy every tool in [its] arsenal” to do it for them. More specifically, the president asked drug firms to base U.S. drug prices for a given drug ...
